Finance

Beta
Lists
ORYZF:OTCMKTS
Oryzon Genomics SA
$3.70
0.00%
(0.00) 1D
May 21, 9:56:40 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORYZF...
Mkt. cap
241.10M
Avg. vol.
30.00
Volume
0.00
52-wk high
$4.38
52-wk low
$3.22
Beta
-616.42
Shares outstanding
79.89M
No. of employees
46
Mkt. cap
241.10M
Avg. vol.
30.00
Volume
0.00
52-wk high
$4.38
52-wk low
$3.22
Beta
-616.42
Shares outstanding
79.89M
No. of employees
46
News stories
From sources across the web
About Oryzon Genomics SA
CEOCarlos Buesa
Employees46
Founded2000
Headquarters-
SectorBiotechnology
Websiteoryzon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
4.22M
-
10.93M
Cost of goods sold
-
147.25K
-
282.49K
Cost of revenue
-
147.25K
-
282.49K
Research and development expenses
-
-2.20M
-
-8.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.45M
-
480.49K
Operating expense
-
3.81M
-
4.85M
Total operating expenses
-
3.95M
-
5.14M
Operating income
-
265.77K
-
5.80M
Other non operating income
-
-1.89M
-
-8.22M
EBT including unusual items
-
-1.31M
-
-4.34M
EBT excluding unusual items
-
-1.31M
-
-4.34M
Income tax expense
-
-1.28M
-
-2.99M
Effective tax rate
-
97.62%
-
68.94%
Other operating expenses
-
4.48M
-
12.44M
Net income
-
-31.27K
-
-1.35M
Net profit margin
-
-0.74%
-
-12.33%
Earnings per share
-0.03
-
0.01
-0.02
Interest and investment income
-
380.08K
-
-
Interest expense
-
-121.42K
-
-1.98M
Net interest expenses
-
258.66K
-
-1.98M
Depreciation and amortization charges
-
70.05K
-
133.91K
EBITDA
-
296.28K
-
5.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer